Why Agilent Technologies, Inc. (A) stock moved
No significant move on Nov 19, 2026 (−1.1%, close-to-close). Latest notable session: Nov 18, 2026.
Why Agilent Technologies, Inc. (A) rose 3.0% on November 18, 2026
Agilent Technologies, Inc. (A) rose 3.0% on November 18, 2026, closing at $177.33 versus $172.22 the prior session (close-to-close, from daily closes). We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, modestly elevated. Source: FMP price data; BestStocks detection.
Agilent Technologies, Inc. (A) moved +2.59% from $172.86 to $177.33 on 2026-11-18. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, modestly elevated.
What to watch next: Agilent's Q4 2026 earnings report on 2026-11-23 will show actual results against the $1.73 consensus estimate.
Earlier sessions that moved A
- −3.0%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- −3.5%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- +2.7%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- −3.3%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- +4.5%Agilent Technologies (NYSE: A) stock climbed over 4% on September 24, 2026, reaching a new 52-week high of $172.68.
- +3.3%Agilent Technologies Inc (NYSE: A) stock is up over 2.7% to around $166.40 in intraday trading on September 22, 2026, driven by a strong technical breakout past key resistance levels, sustained positive momentum following recent upbeat quarterly earnings and raised guidance, and recent announcements including its newly launched FDA-cleared S540MD slide scanner system and expanding digital pathology offerings.
- +3.5%Agilent launched the TapeStationDx systems (4150 and 4200 models) for clinical next-generation sequencing sample quality control, announced today via Business Wire.
Agilent Technologies, Inc. (A) shares fell 1.1% to $175.34 as of November 19, 2026, a modest decline from the prior close of $177.33. BestStocks flagged the session as a major change for A. The move is tied to company news. Below, we break down what changed for A, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
Agilent will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on December 1. Conference participation provides investors direct access to management commentary on strategy and business outlook.
What it means for Agilent Technologies, Inc. investors
For Agilent Technologies, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 1.1%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $174.29, implying -0.6% downside from $175.34. BestStocks rates the overall signal quality weak (39/100). With earnings roughly 4 days out, the next report is the most likely near-term test of the move.
A price reaction
A last traded at $175.34, down $1.99 (-1.12%) from the previous close of $177.33. The session traded on 1.0× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $169.90 and $181.48, and it currently sits about 47% of the way up that band.
Bullish and bearish analyst opinions on Agilent Technologies, Inc. (A)
The consensus analyst price target on Agilent Technologies, Inc. (A) is $174.29, 0.6% below the recent $175.34. Over the past 90 days analysts logged 0 upgrades, 14 maintains, and 0 downgrades. Here is how the bullish and bearish cases on A line up.
The bullish case
- The Street's most bullish target is $195.00 (+11.2%).
- Positive price momentum.
The bearish case
- The consensus analyst price target of $174.29 sits 0.6% below the recent $175.34, so the average target sees limited room to run.
- The most bearish analyst target is $150.00 (-14.5%).
- Negative session, down 1.1%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 19, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for A
Frequently asked questions about A
Why did Agilent Technologies, Inc. (A) stock move?
Agilent Technologies, Inc. (A) rose 3.0% on November 18, 2026, closing at $177.33 versus $172.22 the prior session (close-to-close, from daily closes). We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, modestly elevated. Source: FMP price data; BestStocks detection.
How much did A stock fall?
A lost 1.12% ($1.99) versus the prior close of $177.33, last trading at $175.34 on 1.0× average volume.
When is Agilent Technologies, Inc.'s next earnings date?
A's next earnings report is estimated for 2026-11-23 — about 4 days away.
What is the analyst price target for A?
The consensus analyst price target for A is $174.29, about 0.6% below the current $175.34. Over the past 90 days, analysts recorded 0 upgrades, 14 maintains, and 0 downgrades.
How BestStocks tracks A
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for A, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 19, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
